
Adipocyte Interactions and Immunomodulation in Triple-Negative Breast Cancer
Adipocyte Interactions and Immunomodulation in Triple-Negative Breast Cancer Adipocyte Interactions and Immunomodulation in Triple-Negative Breast Cancer

Adipocyte Interactions and Immunomodulation in Triple-Negative Breast Cancer Adipocyte Interactions and Immunomodulation in Triple-Negative Breast Cancer

Obesity and its related metabolic diseases, such as type 2 diabetes, represent a growing global health

Authors: Mathilde Cadoux, PhD; Emilie Ouanounou; Ghofrane Ben Messaoud; Hadhemi Mejri; Julius Elliot Nyegaard Grothen, PhD;

Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of

The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional

Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty

Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet

Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue

What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a

As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue